HY-N0331-5mg
|
MedChemexpress LLC
|
Ziyuglycoside I [CAS 35286-58-9]
|
|
Cancer-programmed cell death
|
|
HY-N0331-50mg
|
MedChemexpress LLC
|
Ziyuglycoside I [CAS 35286-58-9]
|
|
Cancer-programmed cell death
|
|
HY-N0331-1mL
|
MedChemexpress LLC
|
Ziyuglycoside I [CAS 35286-58-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-123931-10mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-100mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-5mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-50mg
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8]
|
|
Cancer-programmed cell death
|
|
HY-123931-1mL
|
MedChemexpress LLC
|
ZLDI-8 [CAS 667880-38-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-B0124-200mg
|
MedChemexpress LLC
|
Zonisamide [CAS 68291-97-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0124-500mg
|
MedChemexpress LLC
|
Zonisamide [CAS 68291-97-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0124-1mL
|
MedChemexpress LLC
|
Zonisamide [CAS 68291-97-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-D1877-1mg
|
MedChemexpress LLC
|
ZY-1
|
|
|
|
HY-D1877-10mg
|
MedChemexpress LLC
|
ZY-1
|
|
|
|
HY-D1877-25mg
|
MedChemexpress LLC
|
ZY-1
|
|
|
|
HY-D1877-5mg
|
MedChemexpress LLC
|
ZY-1
|
|
|
|
HY-P71673-10ug
|
MedChemexpress LLC
|
ZYX, Human (HEK293, His)
|
|
|
|
HY-P71673-5ug
|
MedChemexpress LLC
|
ZYX, Human (HEK293, His)
|
|
|
|
HY-P71673-50ug
|
MedChemexpress LLC
|
ZYX, Human (HEK293, His)
|
|
|
|